Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,056,466
  • Shares Outstanding, K 259,983
  • Annual Sales, $ 6,403 M
  • Annual Income, $ 864,000 K
  • EBIT $ 1,203 M
  • EBITDA $ 1,480 M
  • 60-Month Beta 0.58
  • Price/Sales 0.33
  • Price/Cash Flow 1.67
  • Price/Book 2.36

Options Overview Details

View History
  • Implied Volatility 73.86% (-2.58%)
  • Historical Volatility 48.48%
  • IV Percentile 92%
  • IV Rank 68.55%
  • IV High 91.71% on 11/05/25
  • IV Low 34.94% on 03/19/25
  • Expected Move (DTE 10) 0.98 (12.36%)
  • Put/Call Vol Ratio 1.30
  • Today's Volume 1,694
  • Volume Avg (30-Day) 5,259
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 134,787
  • Open Int (30-Day) 125,141
  • Expected Range 6.93 to 8.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.71
  • Number of Estimates 3
  • High Estimate 0.76
  • Low Estimate 0.68
  • Prior Year 0.83
  • Growth Rate Est. (year over year) -14.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.74 +2.39%
on 02/09/26
9.94 -20.27%
on 01/23/26
-0.13 (-1.55%)
since 01/09/26
3-Month
6.75 +17.41%
on 12/19/25
9.94 -20.27%
on 01/23/26
+0.22 (+2.79%)
since 11/10/25
52-Week
6.18 +28.24%
on 10/30/25
17.23 -54.00%
on 02/13/25
-7.11 (-47.31%)
since 02/10/25

Most Recent Stories

More News
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off

2 Healthcare Stocks with Promising Prospects and 1 We Brush Off

OGN : 7.93 (+0.25%)
ALHC : 20.40 (-1.73%)
IRTC : 151.89 (+2.28%)
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its fourth quarter and full year 2025 financial results on February 12, 2026, prior to the company’s...

OGN : 7.93 (+0.25%)
Organon Completes Divestiture of JADA® System to Laborie

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today the successful closing of the sale of its JADA ...

OGN : 7.93 (+0.25%)
Why Are Organon (OGN) Shares Soaring Today

Why Are Organon (OGN) Shares Soaring Today

OGN : 7.93 (+0.25%)
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has...

OGN : 7.93 (+0.25%)
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway

The agreement builds on Organon’s cardiovascular disease portfolio, leveraging expertise to expand access to new treatments for patients with dyslipidemia, especially statin-intolerant patients. ...

OGN : 7.93 (+0.25%)
3 Small-Cap Stocks We Approach with Caution

3 Small-Cap Stocks We Approach with Caution

TREX : 45.07 (+2.92%)
OGN : 7.93 (+0.25%)
MEC : 21.65 (+2.07%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

OGN : 7.93 (+0.25%)
SEM : 15.81 (+1.09%)
AMPH : 28.79 (+0.63%)
Why Organon (OGN) Shares Are Trading Lower Today

Why Organon (OGN) Shares Are Trading Lower Today

OGN : 7.93 (+0.25%)
3 Stocks Under $10 We Steer Clear Of

3 Stocks Under $10 We Steer Clear Of

VSTS : 8.80 (+20.22%)
OGN : 7.93 (+0.25%)
NEOG : 10.82 (+1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 8.65
2nd Resistance Point 8.43
1st Resistance Point 8.17
Last Price 7.93
1st Support Level 7.69
2nd Support Level 7.48
3rd Support Level 7.22

See More

52-Week High 17.23
Fibonacci 61.8% 13.01
Fibonacci 50% 11.70
Fibonacci 38.2% 10.40
Last Price 7.93
52-Week Low 6.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar